[go: up one dir, main page]

MX2009009853A - Composicion anestesica nanoparticulada para la administracion topica. - Google Patents

Composicion anestesica nanoparticulada para la administracion topica.

Info

Publication number
MX2009009853A
MX2009009853A MX2009009853A MX2009009853A MX2009009853A MX 2009009853 A MX2009009853 A MX 2009009853A MX 2009009853 A MX2009009853 A MX 2009009853A MX 2009009853 A MX2009009853 A MX 2009009853A MX 2009009853 A MX2009009853 A MX 2009009853A
Authority
MX
Mexico
Prior art keywords
nanoparticulated
anesthetic composition
topic use
composition
anaesthetic
Prior art date
Application number
MX2009009853A
Other languages
English (en)
Inventor
Dante Junior Alario
Silvia Staniscuaski Guterres
Adriana Raffin Pohlmann
Lali Ronsoni Zancan
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009009853(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Publication of MX2009009853A publication Critical patent/MX2009009853A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición anestésica nanoparticulada para administración tópica donde por lo menos un agente anestésico local está encapsulado en nanopartículas poliméricas. La presente invención también se refiere al uso de dichas nanopartículas poliméricas que comprenden por lo menos un agente anestésico local, en la preparación de una composición anestésica para la administración tópica sobre la piel o mucosas.
MX2009009853A 2007-03-16 2008-03-12 Composicion anestesica nanoparticulada para la administracion topica. MX2009009853A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína
PCT/BR2008/000070 WO2008113144A1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use

Publications (1)

Publication Number Publication Date
MX2009009853A true MX2009009853A (es) 2010-02-18

Family

ID=39765309

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009853A MX2009009853A (es) 2007-03-16 2008-03-12 Composicion anestesica nanoparticulada para la administracion topica.

Country Status (15)

Country Link
US (1) US8568788B2 (es)
EP (1) EP2134334B1 (es)
JP (1) JP5496684B2 (es)
AR (1) AR065723A1 (es)
BR (1) BRPI0700832B8 (es)
CL (1) CL2008000728A1 (es)
CO (1) CO6220944A2 (es)
EC (1) ECSP099691A (es)
ES (1) ES2804466T3 (es)
HU (1) HUE051155T2 (es)
MX (1) MX2009009853A (es)
PE (2) PE20081883A1 (es)
PL (1) PL2134334T3 (es)
PT (1) PT2134334T (es)
WO (1) WO2008113144A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2344329T3 (pl) 2008-10-02 2013-05-31 Mylan Inc Sposób wytwarzania wielowarstwowego laminatu przylepnego
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных
CN119950421B (zh) * 2025-04-11 2025-07-08 北华大学 一种含有三甲卡因的麻醉制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
WO1999001114A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US20080124400A1 (en) 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
US8940311B2 (en) * 2004-10-21 2015-01-27 Tae-Hong Lim In situ controlled release drug delivery system
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
BRPI0700832B8 (pt) 2021-05-25
JP2010521498A (ja) 2010-06-24
ECSP099691A (es) 2010-02-26
EP2134334A1 (en) 2009-12-23
US20100086614A1 (en) 2010-04-08
ES2804466T3 (es) 2021-02-08
US8568788B2 (en) 2013-10-29
BRPI0700832A (pt) 2008-11-04
WO2008113144A1 (en) 2008-09-25
CL2008000728A1 (es) 2008-09-26
CO6220944A2 (es) 2010-11-19
JP5496684B2 (ja) 2014-05-21
EP2134334A4 (en) 2013-04-24
HUE051155T2 (hu) 2021-03-01
PE20081883A1 (es) 2008-12-27
EP2134334B1 (en) 2020-05-13
PL2134334T3 (pl) 2021-03-08
AR065723A1 (es) 2009-06-24
PE20131337A1 (es) 2013-11-18
PT2134334T (pt) 2020-08-20
BRPI0700832B1 (pt) 2017-12-26

Similar Documents

Publication Publication Date Title
MX2009009853A (es) Composicion anestesica nanoparticulada para la administracion topica.
MX2009007254A (es) Composiciones de tableta en tableta.
UY32497A (es) "2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso"
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
HN2009000784A (es) Dihidropirazolonas sustituidas
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
WO2008089268A3 (en) Methods and compositions for treating conditions associated with infection and/or inflammation
NZ589228A (en) Combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of a brain tumour
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
BRPI1103213B8 (pt) Composição de enxaguatório bucal antimicrobiano com teor alcoólico reduzido à base de óleo essencial bioativo
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
IL201479A (en) Use of tapentadol for the preparation of pain medication
MX2008011978A (es) Tratamiento del cancer de seno negativo al triple receptor.
MY156275A (en) Compositions comprising tramadol and celecoxib in the treatment of pain
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
CR10305A (es) "derivados sustituidos de cromanol y su uso.
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MX2009011900A (es) Curacion de herida diabetica.
BR112012019921A2 (pt) composições líquidas compreendendo um agente de resfriamento não-metol e um espessante para tratamento de um sintoma respiratório.
UA87841C2 (ru) Композиция, которая содержит амброксол, для местного применения
CY1109733T1 (el) Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
TNSN08506A1 (en) Substituted carboxamides
WO2008109427A3 (en) Anesthetic spray composition

Legal Events

Date Code Title Description
FG Grant or registration